Long-term study finds modern hormone replacement therapy not linked to heart disease risk
Research Highlights: A large, long-term study of over 52,000 women in Israel found that among women ages 45 to 59, initiation of contemporary hormone replacement therapy did not increase the risk of heart attack, stroke, blood clots or death. The independent, preliminary study had an average follow-up of 12 years and included hormone replacement therapy in oral, transdermal (patch) or gel form. Note: The study featured in this news release is a research abstract. Abstracts presented at American Heart Association’s scientific meetings are not peer-reviewed, and the findings are considered preliminary until published as a full manuscript in a peer-reviewed scientific journal. Embargoed until 4 a.m. CT/5 a.m. ET, Monday, Nov. 2, 2026 November 2, 2026 ( NEWMEDIAWIRE ) - DALLAS - Contemporary hormone replacement therapy (HRT) was not associated with an increased risk for heart attack, stroke, blood clots or death among women ages 45 to 59, according to a large, long-term study of over 52,000 women in Israel. The findings from this new, independent, preliminary research will be presented at the American Heart Association’s Scientific Sessions 2026 . The meeting, Nov. 6-9, in Chicago, is
Free plan · Plus CA$29 or Pro CA$99/month


